Ad-hoc Announcements 2010

Here you find Ad-hoc messages of year 2010.

To view the PDF documents you will need the Acrobat Reader. Please click here to download the free Adobe Acrobat Reader software. 

October 31, 2010

Bayer AG: Phase III ROCKET AF Study of Rivaroxaban meets its primary efficacy endpoint with Comparable Safety vs. Warfarin

Download PDF collect (41 KB)


August 4, 2010

Bayer AG: Rivaroxaban Meets Primary Endpoint in Long-Term Phase III EINSTEIN-DVT Study

Download PDF collect (37 KB)


Investor News issued in year 2010 can be found here.

Publications of the previous years are offered in the Archive Overview.